. Author manuscript; available in PMC: 2021 Mar 30.

Published in final edited form as: Palliat Med. 2019 Feb 7;33(4):452–456. doi: 10.1177/0269216318824270

Table 3.

Value-based outcomes.

	p-value (favors palliative)	Palliative consult (n = 3187)	One-to-many matched controls (n = 25,028)	p-value (favors controls)
7-day readmit (%)	<0.001	184 (5.8)	1866 (7.5)
30-day readmit (%)	<0.001	500 (15.7)	5083 (20.3)
90-day readmit (%)	<0.001	827 (26.0)	8543 (34.1)
Dialysis (%)		270 (8.5)	1802 (7.2)	0.01
C-diff (%)		43 (1.4)	163 (0.6)	<0.001
Post-op infection		2 (0.1)	47 (0.2)
CAUTI		2 (0.1)	24 (0.1)
MRSA		107 (3.4)	433 (1.7)	<0.001
Ventilator hours (SD)		108 (117)	55 (264)	<0.001

C-diff: Clostridium difficile; CAUTI: catheter-associated urinary tract infection; MRSA: methicillin-resistant Staphylococcus aureus; SD: standard deviation.